Risk factors for cerebral hypoperfusion, mild cognitive impairment, and dementia

Neurobiology of Aging

Volumn 21, Issue 2, 2000, Pages 161-169

  Meyer, John S ^a,b   Rauch, Gaiane ^a,b   Rauch, Ronald A ^a,b   Haque, A ^a,b  

^a MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Aging; Cerebral hypoperfusion; Cognitive decline; Dementia; Neuroimaging; Risk factors; Xe CT CBF

Indexed keywords

XENON;

ADULT; AGE; AGED; AGING; ALZHEIMER DISEASE; BRAIN ATROPHY; BRAIN PERFUSION; COGNITIVE DEFECT; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; DEMENTIA; DENSITOMETRY; FEMALE; FOLLOW UP; GRAY MATTER; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; IMAGING; MALE; MULTIINFARCT DEMENTIA; NORMAL HUMAN; PRIORITY JOURNAL; RISK FACTOR; SMOKING; TRANSIENT ISCHEMIC ATTACK; VOLUNTEER; WHITE MATTER;

ADULT; AGED; AGED, 80 AND OVER; AGING; ALCOHOL DRINKING; BRAIN; CEREBROVASCULAR CIRCULATION; CEREBROVASCULAR DISORDERS; COGNITION DISORDERS; DEMENTIA, VASCULAR; DENSITOMETRY; DIABETES COMPLICATIONS; EDUCATION; FEMALE; HEART DISEASES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; RISK FACTORS; SEX FACTORS;

EID: 0034603524     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(00)00136-6     Document Type: Conference Paper

References (66)

1. Akiyama H., Meyer J.S., Mortel K.F., Terayama Y., Thornby J.I., Konno S. Normal human aging factors contributing to cerebral atrophy . J Neurol Sci. 152:1997;39-49.
2. Albert M., Naeser M.A., Levine H.L., Garvey A.J. Ventricular size in patients with presenile dementia of the Alzheimer's type. Arch Neurol. 41:1984;1258-1263.
3. Diagnostic and statistical manual of related disorders. 3rd ed. rev. 1987;American Psychiatric Press, Washington DC.
4. Anderson J.M., Hubbard B.M., Coghill G.R., Slidders W. The effect of advanced old age on the neurone content of the cerebral cortex. Observations with an automatic image analyzer point counting method. J Neurol Sci. 58:1983;235-246.
5. Awad I.A., Spetzler R.F., Hodak J.A., Awad C.A., Carey R. Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. I. Correlation with age and cerebrovascular risk factors. Stroke. 17:1986;1084-1089.
6. Barclay L., Zemcov A., Blass J.P., McDowell F. Rates of decrease of cerebral blood flow in progressive dementias. Neurology. 34:1984;1555-1560.
7. Bredesen D.E. Neural apoptosis. Ann Neurol. 38:1995;839-851.
8. Brenner D.E., Kukull W.A., van Belle G., et al. Relationship between cigarette smoking and Alzheimer's disease in a population-based case-control study. Neurology. 43:1993;293-300.
9. Burns A., Jacoby R., Levy R. Computed tomography in Alzheimer's disease a longitudinal study . Biol Psychiatry. 29:1991;383-390.
10. Carmelli D., Swan G.E., Reed T., Wolf P.A., Miller B.L., DeCarli C. Midlife cardiovascular risk factors and brain morphology in identical older male twins. Neurology. 52:1999;1119-1124.
11. Charriaut-Marlangue C., Margaill I., Represa A., Popovici T., Plotkine M., Ben-Ari Y. Apoptosis and necrosis after reversible focal ischemia an in situ DNA fragmentation analysis . J Cereb Blood Flow Metab. 16:1996;186-194.
12. DeCarli C., Haxby J.V., Gillette J.A., Teichberg D., Rapoport S.I., Schapiro M.B. Longitudinal changes in lateral ventricular volume in patients with dementia of the Alzheimer type. Neurology. 42:1992;2029-2036.
13. De Leon M.J., George A.E., Reisberg B., et al. Alzheimer's disease longitudinal CT studies of ventricular change . Am J Neuroradiol. 10:1989;371-376.
14. Desmond D.W. Vascular dementia a construct in evolution . Cerebrovasc Brain Metab Rev. 8:1996;296-325.
15. Earnest M.P., Heaton R.K., Wilkinson W.E., Manke W.F. Cortical atrophy, ventricular enlargement and intellectual impairment in the aged. Neurology. 29:1979;1138-1143.
16. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-Mental State" a practical method for grading the cognitive state of patients for the clinician . J Psychiat Res. 12:1975;189-198.
17. George A.E., De Leon M.J., Gentes C.I., et al. Leukoencephalopathy in normal and pathologic aging. 1. CT of brain lucencies. Am J Neuroradiol. 7:1986;561-566.
18. Gold G., Giannakopoulos P., Montes-Paixao C., et al. Sensitivity and specificity of newly proposed clinical criteria for possible vascular dementia. Neurology. 49:1997;690-694.
19. Grigoletto F., Zappala G., Anderson D.W., Lebowitz B. Norms for the Mini-Mental State Examination in a healthy population. Neurology. 53:1999;315-320.
20. Hachinski V.C., Potter P., Merskey H. Leuko-araiosis. Arch Neurol. 44:1987;21-23.
21. Hebert P.R., Gaziano J.M., Chan K.S., Hennekens C.H. Cholesterol lowering with statin drugs, risk of stroke, and total mortality. JAMA. 278:1997;313-321.
22. Hershey L.A., Jaffe D.F., Greenough P.G., Yang S-L. Validation of cognitive and functional assessment instruments in vascular dementia. Int J Psychiatry Med. 17:1987;183-192.
23. Inzitari D., Diaz F., Fox A., et al. Vascular risk factors and leuko-araiosis. Arch Neurol. 44:1987;42-47.
24. Jacobs J.W., Bernhard M.R., Delgado A., Strain J.L. Screening for organic mental syndromes in the medically ill. Ann Intern Med. 86:1977;40-46.
25. Katzman R., Aronson M., Fuld P., et al. Development of dementing illnesses in an 80-year-old volunteer cohort. Ann Neurol. 25:1989;317-324.
26. Kaufman D.M., Weinberg M., Strain J.J. Detection of cognitive deficits by a brief mental state examination the Cognitive Capacity Screening Examination, a reappraisal and a review . Gen Hosp Psychiatry. 1:1979;247-255.
27. Kazniak A.W., Garron D.C., Fox J.H., Bergen D., Huckman M. Cerebral atrophy, EEG slowing, age, education, and cognitive functioning in suspected dementia. Neurology. 29:1979;1273-1279.
28. Kety S.S. Human cerebral blood flow and oxygen consumption as related to aging. J Chronic Dis. 3:1956;478-486.
29. Kobari M., Meyer J.S., Ichijo M., Oravez W.T. Leukoaraiosis. Correlation of MR and CT findings with blood flow, atrophy, and cognition. Am J Neuroradiol. 11:1990;273-281.
30. Kokmen E., Beard C.M., Chandra V., Offord K.P., Schoenberg B.S., Ballard D.J. Clinical risk factors for Alzheimer's disease a population-based case-control study . Neurology. 41:1991;1393-1397.
31. Konno S., Meyer J.S., Terayama Y., Margishvili G.M., Mortel K.F. Classification, diagnosis and treatment of vascular dementia. Drugs Aging. 5:1997;361-373.
32. The challenge of the dementias. Lancet. 347:1996;1303-1307.
33. Landin K., Blennow K., Wallin A., Gottfries C. Low blood pressure and blood glucose levels in Alzheimer's disease evidence for a hypometabolic disorder? J Intern Med. 233:1993;357-362.
34. Loeb C., Meyer J.S. Vascular dementia still a debatable entity? J Neurol Sci. 143:1996;31-40.
35. Martin A.J., Friston K.J., Colebatch J.G., Frackowiak R.S.J. Decrease in regional cerebral blood flow with normal aging. J Cereb Blood Flow Metab. 11:1991;684-689.
36. Masliah E., Mallory M., Hansen L., DeTeresa R., Terry R.D. Quantitative synaptic alterations in the human neocortex during normal aging. Neurology. 43:1993;192-197.
37. Meyer J.S., Shinohara T., Imai A., et al. Imaging local cerebral blood flow by Xenon-enhanced computed tomography technical optimization procedures . Neuroradiology. 30:1988;283-292.
38. Meyer J.S., Takashima S., Terayama Y., Obara K., Muramatsu K., Weathers S. CT changes associated with normal aging of the human brain. J Neurol Sci. 123:1994;200-208.
39. Meyer J.S., Obara K., Takashima S. Problems encountered with longitudinal neurological, psychometric and cerebral CT imaging among stroke data bank patients with dementia. Neuroepidemiology. 13:1994;340-344.
40. Meyer J.S., Shirai T., Muramatsu K., Mortel K.F. Effects of chronic cigarette smoking and abstention on cerebral perfusion among neurologically normal volunteers. Domino E.F. Brain imaging of nicotine and tobacco smoking. 1995;137-151 NPP Books.
41. Meyer J.S., Muramatsu K., Mortel K.F., Obara K., Shirai T. Prospective CT confirms differences between vascular and Alzheimer's dementia. Stroke. 26:1995;735-742.
42. Meyer J.S., Terayama Y., Takashima S., Obara K. Computed tomography cerebral blood flow values compared in normal aging, ischemic vascular dementia, and Alzheimer's disease. Tomonaga M., Tanaka A., Yonas H. Quantitative cerebral blood flow measurements using stable xenon/CT clinical applications . 1995;321-329 Futura Publishing, New York.
43. Meyer J.S., Rauch G.M., Crawford K., et al. Risk factors accelerating cerebral degenerative changes cognitive dcline and dementia. Int J Geriatr Psychiatry. 14:1999;1050-1061.
44. Moroney J.T., Tang M.X., Beglund L., et al. Low-density lipoprotein cholesterol and the risk of dementia with stroke. J Am Med Assoc. 288:1999;254-260.
45. Obara K., Meyer J.S., Mortel K.F., Muramatsu K. Cognitive declines correlate with decreased cortical volume and perfusion in dementia of Alzheimer type. J Neurol Sci. 127:1994;96-102.
46. Persson G., Skoog I. A prospective population study of psychosocial risk factors for late onset dementia. Int J Geriatr Psychiatry. 11:1996;15-22.
47. Peters A., Rosene D.L., Moss M.B., et al. Neurobiological bases of age-related cognitive decline in the rhesus monkey. J Neuropathol Exp Neurol. 55:1996;861-874.
48. Petersen R.C., Smith G.E., Waring S.C., Ivnik R.J., Tangalos E.G., Kokmen E. Mild cognitive impairment. Arch Neurol. 56:1999;303-308.
49. Raiha I., Tarvonen S., Kurki T., Rajala T., Sourander L. Relationship between vascular factors and white matter low attenuation of the brain. Acta Neurol Scand. 87:1993;286-289.
50. Ross G.W., Petrovich H., White L.R., et al. Characterization of risk factors for vascular dementia. The Honolulu-Asia Aging Study. Neurology. 53:1999;337-343.
51. Salat D.H., Kaye J.A., Janowsky J.S. Prefrontal gray and white matter volumes in healthy aging and Alzheimer disease. Arch Neurol. 56:1999;338-344.
52. Schofield P.W., Logroscino G., Andrews H.F., Albert S., Stern Y. An association between head circumference and Alzheimer's disease in a population-based study of aging and dementia. Neurology. 49:1997;30-37.
53. Schwartz M., Creasey H., Grady C.L., et al. Computed tomographic analysis of brain morphometrics in 30 healthy men, aged 21-81 years. Ann Neurol. 17:1985;146-157.
54. Shear P.K., Sullivan E.V., Mathalon D.H., et al. Longitudinal volumetric computed tomographic analysis of regional brain changes in normal aging and Alzheimer's disease. Arch Neurol. 52:1995;392-402.
55. Skoog I. Risk factors for vascular dementia a review . Dementia. 5:1994;137-144.
56. Skoog I., Lernfelt B., Landahl S., et al. 15-year longitudinal study of blood pressure and dementia. Lancet. 347:1996;1141-1145.
57. Soininen H., Heinonen O.P. Clinical and etiological aspects of senile dementia. Eur Neurol. 21:1982;401-410.
58. Steingart A., Hachinski V.C., Lau C., et al. Cognitive and neurologic findings in demented patients with diffuse white matter lucencies on computed tomographic scan (leuko-araiosis). Arch Neurol. 44:1987;36-39.
59. Strassburger T.L., Lee H.-C., Daly E.M., et al. Interactive effects of age and hypertension on volumes of brain structures. Stroke. 28:1997;1410-1417.
60. Sullivan P., Pary R., Telang F., Rifai A.H., Zubenko G.S. Risk factors for white matter changes detected by magnetic resonance imaging in elderly. Stroke. 21:1990;1424-1428.
61. Takeda S., Watanabe H., Matsuzawa T. Association of atherosclerosis with increased atrophy of brain matter in the elderly. J Am Geriatr Soc. 34:1986;259-262.
62. Terayama Y., Meyer J.S., Takashima S., Obara K., Weathers S. Comparison of polio-araiosis and leuko-araiosis in dementias of ischemic vascular and Alzheimer types. J Stroke Cerebrovasc Dis. 3:1993;267-275.
63. Terry R.D., DeTeresa R., Hansen L.A. Neocortical cell counts in normal human adult aging. Ann Neurol. 21:1987;530-539.
64. Van Duijn C.M., Hofman A. Relation between nicotine intake and Alzheimer's disease. Br Med J. 27:1991;1244-1248.
65. Van Zagten M., Boiten J., Kessels F., Lodder J. Significant progression of white matter lesions and small deep (lacunar) infarcts in patients with stroke. Arch Neurol. 53:1996;650-655.
66. Waldemar G. Functional brain imaging with SPECT in normal aging and dementia. Cerebrovasc Brain Metab Rev. 7:1995;89-130.